KMT2D deficiency drives lung squamous cell carcinoma and hypersensitivity to RTK-RAS inhibitionYuanwang Pan, Kwok‐Kin Wong, Han Han et al.|Cancer Cell|2022Cited by 99
Targeted degradation of oncogenic KRASG12V triggers antitumor immunity in lung cancer modelsDezhi Li, Hua Zhang, Saurav Kumar et al.|Journal of Clinical Investigation|2024Cited by 16